Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $11.70 $16.59 Friday, 10th May 2024 NVCR stock ended at $16.47. This is 2.11% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 3.56% from a day low at $16.02 to a day high of $16.59.
90 days $11.70 $18.04
52 weeks $10.87 $83.60

Historical NovoCure Limited prices

Date Open High Low Close Volume
Feb 12, 2016 $12.72 $12.90 $11.93 $12.11 132 600
Feb 11, 2016 $12.71 $13.13 $11.76 $12.06 198 400
Feb 10, 2016 $12.55 $13.23 $12.38 $13.12 172 300
Feb 09, 2016 $11.90 $13.06 $11.75 $12.69 420 000
Feb 08, 2016 $11.32 $12.38 $11.23 $12.31 233 200
Feb 05, 2016 $11.81 $12.35 $11.40 $11.46 285 000
Feb 04, 2016 $10.75 $12.20 $10.75 $11.81 565 400
Feb 03, 2016 $10.93 $11.06 $10.16 $11.03 306 000
Feb 02, 2016 $11.18 $12.00 $10.15 $10.30 346 000
Feb 01, 2016 $12.43 $12.44 $11.23 $11.29 387 100
Jan 29, 2016 $12.77 $13.49 $11.30 $12.48 505 600
Jan 28, 2016 $14.09 $14.09 $12.82 $12.99 296 500
Jan 27, 2016 $14.50 $14.81 $13.86 $14.09 205 000
Jan 26, 2016 $14.50 $14.73 $14.05 $14.51 176 600
Jan 25, 2016 $14.00 $15.10 $13.70 $14.50 424 000
Jan 22, 2016 $15.48 $15.60 $13.52 $13.81 649 700
Jan 21, 2016 $14.56 $15.96 $14.56 $15.05 733 000
Jan 20, 2016 $16.51 $17.31 $13.56 $14.23 1 117 200
Jan 19, 2016 $17.52 $17.67 $16.07 $17.06 514 300
Jan 15, 2016 $18.72 $18.81 $17.44 $17.79 355 800
Jan 14, 2016 $20.18 $20.30 $19.11 $19.30 436 500
Jan 13, 2016 $22.09 $22.49 $20.36 $20.48 312 200
Jan 12, 2016 $20.37 $21.90 $20.37 $21.90 324 300
Jan 11, 2016 $20.20 $21.35 $19.46 $20.55 394 300
Jan 08, 2016 $19.80 $20.68 $19.80 $20.15 468 100
Click to get the best stock tips daily for free!

About NovoCure Limited

NovoCure Limited NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed c... NVCR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT